155 related articles for article (PubMed ID: 25008192)
1. Comparison of colorectal cancer screening and diagnoses in HIV-positive and HIV-negative veterans.
Guest JL; Rentsch CT; Rimland D
AIDS Care; 2014; 26(12):1490-3. PubMed ID: 25008192
[TBL] [Abstract][Full Text] [Related]
2. Screening Women Aged 50-59 for CRC Using Fecal Occult Blood Test Produces Outcomes Similar to Men Undergoing Screening Colonoscopy.
Mooers HM; Holub JL; Lieberman DA
Dig Dis Sci; 2018 Oct; 63(10):2780-2785. PubMed ID: 29948570
[TBL] [Abstract][Full Text] [Related]
3. Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration.
Powell AA; Saini SD; Breitenstein MK; Noorbaloochi S; Cutting A; Fisher DA; Bloomfield HE; Halek K; Partin MR
J Gen Intern Med; 2015 Jun; 30(6):732-41. PubMed ID: 25605531
[TBL] [Abstract][Full Text] [Related]
4. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
5. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients.
Lieberman DA; Holub JL; Moravec MD; Eisen GM; Peters D; Morris CD
JAMA; 2008 Sep; 300(12):1417-22. PubMed ID: 18812532
[TBL] [Abstract][Full Text] [Related]
7. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
8. Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.
Lieberman D; Sullivan BA; Hauser ER; Qin X; Musselwhite LW; O'Leary MC; Redding TS; Madison AN; Bullard AJ; Thomas R; Sims KJ; Williams CD; Hyslop T; Weiss D; Gupta S; Gellad ZF; Robertson DJ; Provenzale D
Gastroenterology; 2020 Mar; 158(4):862-874.e8. PubMed ID: 31376388
[TBL] [Abstract][Full Text] [Related]
9. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
10. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
[TBL] [Abstract][Full Text] [Related]
11. Overuse of colonoscopy for colorectal cancer screening and surveillance.
Kruse GR; Khan SM; Zaslavsky AM; Ayanian JZ; Sequist TD
J Gen Intern Med; 2015 Mar; 30(3):277-83. PubMed ID: 25266407
[TBL] [Abstract][Full Text] [Related]
12. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
Daniels K; McKee M
J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
[TBL] [Abstract][Full Text] [Related]
13. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
14. Options for screening for colorectal cancer.
Atkin W
Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the OC Sensor
Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
[TBL] [Abstract][Full Text] [Related]
16. Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015-2016.
Almansoori A; Alzaabi M; Alketbi L
BMC Cancer; 2021 Aug; 21(1):897. PubMed ID: 34362343
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of colorectal cancer in the human immunodeficiency virus-infected African American population.
Kumar A; Shah N; Modi Y; Shaaban HS; DePasquale J; DeBari VA; Yerrabothala S; Maroules M; Guron GK
Med Oncol; 2012 Sep; 29(3):1773-9. PubMed ID: 21710235
[TBL] [Abstract][Full Text] [Related]
18. Adenoma and advanced neoplasia detection rates increase from 45 years of age.
Karsenti D; Tharsis G; Burtin P; Venezia F; Tordjman G; Gillet A; Samama J; Nahon-Uzan K; Cattan P; Cavicchi M
World J Gastroenterol; 2019 Jan; 25(4):447-456. PubMed ID: 30700941
[TBL] [Abstract][Full Text] [Related]
19. Diverticular Disease and Colorectal Neoplasms: Association between Left Sided Diverticular Disease with Colorectal Cancers and Right Sided with Colonic Polyps.
Wong ER; Idris F; Chong CF; Telisinghe PU; Tan J; Chong VH
Asian Pac J Cancer Prev; 2016; 17(5):2401-5. PubMed ID: 27268604
[TBL] [Abstract][Full Text] [Related]
20. The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening.
Hubbard RA; Johnson E; Hsia R; Rutter CM
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1612-9. PubMed ID: 23868091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
